6 Recruiting Lung Cancer Phase 3 Clinical Trials
Active phase 3 studies for lung cancer enrolling across the USA. Verify eligibility and contact site coordinators.
All Lung Cancer studiesPhase 3 Studies for Lung Cancer
🔵 Active, Not Recruiting Phase3
A Clinical Study of Pembrolizumab (+) Berahyaluronidase Alfa (MK-3475A) to Treat Newly-diagnosed Metastatic Non-small Cell Lung Cancer (MK-3475A-F84)
📍 Providence Medical Foundation ( Site 0117) — Fullerton, California
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3
A Study to Assess Zipalertinib Versus Placebo in Participants With Early Stage NSCLC With Uncommon EGFR Mutations, Following Complete Tumor Resection
📍 Alaska Oncology and Hematology — Anchorage, Alaska
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2 / Phase3
Study of CTDNA Response Adaptive Immuno-Chemotherapy in Lung Cancer
📍 The University of Chicago Medical Center — Chicago, Illinois
View Study & Checklist ➔ 🟡 Not Yet Recruiting Phase3
A Phase 3 Study of 99mTC-EC-DG SPECT/CT Versus PET/CT in Lung Cancer
📍 Decatur Memorial Hospital — Decatur, Illinois
View Study & Checklist ➔ 🟢 Recruiting Phase3
The Thoracic Peri-Operative Integrative Surgical Care Evaluation Trial - Stage III
📍 The Ottawa Hospital — Ottawa, Ontario
View Study & Checklist ➔ 🟢 Recruiting Phase3
Evaluation of the Safety and Efficacy of Abenacianine (VGT-309) to Identify Cancer in Subjects Undergoing Surgery for Cancer in the Lung
📍 City of Hope National Medical Center — Duarte, California
View Study & Checklist ➔